Alkermes plc reiterated earnings guidance for the year 2024. The company reiterates its financial expectations for 2024, as set forth in its press release dated Feb. 15, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.26 USD | +0.31% | -3.11% | -12.51% |
06-17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
06-11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.51% | 4.09B | |
+31.01% | 52.73B | |
+37.49% | 39B | |
-9.14% | 38.52B | |
+28.05% | 30.38B | |
-12.26% | 26.39B | |
+11.61% | 26.08B | |
+45.23% | 14.15B | |
+33.03% | 12.6B | |
-5.38% | 11.51B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Alkermes plc Reiterates Earnings Guidance for the Year 2024